A school-based program for control of group A streptococcal upper respiratory tract infections: A controlled trial in Southern China

Pediatric Infectious Disease Journal

Volumn 27, Issue 8, 2008, Pages 753-755

  Lin, Shuguang ^a   Kaplan, Edward L ^b   Rao, Xuxu ^a   Johnson, Dwight R ^b   Deng, Mulan ^a   Zhuo, Qiling ^a   Yang, Pingzhen ^a   Mai, Jinzhuang ^a   Dong, Taiming ^a   Liu, Xiaoqing ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Group A streptococci; Pharyngitis; School based prevention; Streptococcal upper respiratory tract infection

Indexed keywords

BENZATHINE PENICILLIN; ERYTHROMYCIN; PENICILLIN G; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ARTICLE; CHILD; CHINA; CONTROLLED STUDY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCHOOL HEALTH SERVICE; STREPTOCOCCAL PHARYNGITIS; THROAT CULTURE; UPPER RESPIRATORY TRACT INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HETEROZYGOTE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PHARYNGITIS; PHARYNX; RESPIRATORY TRACT INFECTION; SCHOOL; STATISTICS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHINA; DELIVERY OF HEALTH CARE; ERYTHROMYCIN; FEMALE; HUMANS; INCIDENCE; MALE; PENICILLINS; PHARYNGITIS; PHARYNX; PREVALENCE; PROGRAM EVALUATION; RESPIRATORY TRACT INFECTIONS; SCHOOLS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME;

EID: 51049094930     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31816be02f     Document Type: Article

References (7)

1. Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. The influences and dynamics of population and pathogens: a failure to realize prevention? (The T. Duckett Jones Memorial Lecture). Circulation. 1993;88:1964-1972.
2. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168.
3. Kaplan EL, Mendis S, Bisno AL, et al. Rheumatic Fever and Rheumatic Heart Disease-Report of a World Health Organization Expert Consultation. Geneva: World Health Organization; 2004.
4. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10:673-695.
5. Taranta A, Markowitz M. Rheumatic Fever. Boston, MA: MTP Press Limited; 1981:14-21.
6. WHO Special Study Group. Rheumatic Fever and Rheumatic Heart Disease. Geneva: World Health Organization; 1988.
7. Rotta J. Group and type (groups A and B) identification of haemolytic streptococci. In: Bergan T, Norris JR, eds. Methods in Microbiology. London: Academic Press; 1978:177-198.